ESC Premium Access

BET inhibition, an epigenetic pathway: how could BET inhibition modulate atherothrombotic risk

Topic: Pathophysiology and Mechanisms
Organised by PACE-CME, supported with an educational grant provided by Resverlogix

Congress Presentation

About the speaker

Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))
20 presentations
0 follower

4 more presentations in this session


Speaker: Professor U. Landmesser (Berlin, DE)


Challenges in targeting residual risk in diabetic patients, post ACS

Speaker: Professor P. Libby (Boston, US)


Clinical update on BET inhibition: the patient profile that may benefit from BET inhibition?

Speaker: Professor K. Ray (London, GB)



Speaker: Professor U. Landmesser (Berlin, DE) Professor K. Ray (London, GB)


Access the full session

Epigenetics: a new pathway to tackle residual risk?

Speakers: Professor J. Jukema, Professor U. Landmesser, Professor P. Libby, Professor K. Ray, Professor U. Landmesser...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb